Aprea Therapeutics, Inc.
APRE
$0.90
-$0.03-3.26%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 17.39% | 8.23% | 17.64% | -35.85% | 23.49% |
| Total Depreciation and Amortization | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 31.32% | -28.03% | -2.64% | 96.31% | -52.98% |
| Change in Net Operating Assets | -106.33% | -412.18% | -150.32% | 117.73% | -162.94% |
| Cash from Operations | 6.62% | -1.29% | 13.78% | -3.43% | -42.24% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 1,022.35% | -6.10% | 575.34% | -57.95% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -2,036.21% | -16.78% | -338.24% | 46.88% | -433.33% |
| Cash from Financing | 973.37% | -7.01% | 589.78% | -58.48% | 11,300.00% |
| Foreign Exchange rate Adjustments | 316.67% | -123.08% | 85.71% | 105.69% | -199.60% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 131.33% | -2.57% | 23.24% | -5.08% | -39.12% |